Menu
[et_pb_section fb_built="1" _builder_version="4.24.0" _module_preset="default" width="100%" custom_padding="||21px|||" global_colors_info="{}" theme_builder_area="post_content"][et_pb_row _builder_version="4.24.0" _module_preset="default" width="91.4%" min_height="875.4px" custom_margin="|11px||60px||" custom_padding="||0px|||" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.0" _module_preset="default" min_height="364px" custom_padding="||0px|||" global_colors_info="{}" theme_builder_area="post_content"]
SOPHiA GENETICS is excited to be part of the 8th Annual Liquid Biopsy for Precision Oncology Summit, held in person in San Diego, CA, USA, from February 28 to March 1, 2024.
You will have the chance to chat with our experts and learn more about our collaboration with AstraZeneca and Memorial Sloan Kettering Cancer Center (MSK) to decentralize their MSK-ACCESS® assay.
TALK
Access to Precision Oncology with Decentralized Liquid Biopsy Solutions
Talk, February 29
12-12:30 PM
Track B: Clinical Development & Commercialization
[/et_pb_text][et_pb_text _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"]
Liquid biopsy is emerging as a revolutionary technology, holding promise for swift and precise diagnostics. Despite the potential to positively impact precision oncology and the increasing popularity of NGS-based assays, liquid biopsy faces challenges, including workflow standardization across the globe, regulatory issues, guideline inclusion, and reimbursement hurdles.
Join us in this talk to hear about the SOPHiA GENETICS' journey in expanding access to Liquid Biopsy at a global scale.
[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_button button_url="https://www.addevent.com/event/qM20104787" button_text="SAVE THE DATE" button_alignment="center" _builder_version="4.24.0" _module_preset="default" custom_button="on" button_text_color="#FFFFFF" button_bg_color="#E3295C" button_border_color="#FFFFFF" button_font="||||||||" global_colors_info="{}" theme_builder_area="post_content"][/et_pb_button][/et_pb_column][/et_pb_row][et_pb_row _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.0" _module_preset="default" text_text_color="#E3295C" global_colors_info="{}" theme_builder_area="post_content"]
Learn more about our collaboration with AstraZeneca and MSK 
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built="1" custom_padding_last_edited="on|phone" _builder_version="4.24.0" _module_preset="default" background_color_gradient_direction="90deg" background_enable_image="off" display_conditions="W10=" custom_padding="0px||40px||false|false" custom_padding_tablet="" custom_padding_phone="20px||20px||true|false" custom_css_main_element=" display: flex;|| flex-direction: column;|| justify-content: center;" global_colors_info="{}" theme_builder_area="post_content"][et_pb_row column_structure="1_3,2_3" make_equal="on" admin_label="about the author" _builder_version="4.23.4" background_color="#F3F5F6" background_size="initial" background_position="top_left" background_repeat="repeat" width="95%" max_width="800px" min_height="240px" custom_padding="|120px||120px|false|true" border_radii="on|15px|15px|15px|15px" saved_tabs="all" locked="off" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="1_3" _builder_version="4.22.2" custom_padding="|||" custom_css_main_element="display: flex;||align-items: center;" global_colors_info="{}" custom_padding__hover="|||" theme_builder_area="post_content"][et_pb_image src="https://www.sophiagenetics.com/wp-content/uploads/2024/02/T-Scott-1.png" title_text="T Scott" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][/et_pb_image][/et_pb_column][et_pb_column type="2_3" _builder_version="4.22.2" custom_padding="|||" custom_css_main_element="display: flex;||justify-content: center;||flex-direction: column;" global_colors_info="{}" custom_padding__hover="|||" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.0" _module_preset="default" text_font="|700|||||||" text_font_size="26px" global_colors_info="{}" theme_builder_area="post_content"]
Presented by
[/et_pb_text][et_pb_text _builder_version="4.24.0" _module_preset="default" text_font="||||||||" text_text_color="#0A2E4A" text_font_size="16px" link_font="||||on||||" link_text_color="#FFFFFF" header_text_align="left" header_4_font="||||||||" header_4_text_align="left" header_4_text_color="#0A2E4A" header_4_font_size="19px" custom_margin="||1px|||" global_colors_info="{}" theme_builder_area="post_content"]
T. Scott Reid, PhD
[/et_pb_text][et_pb_text _builder_version="4.24.0" _module_preset="default" text_font="||||||||" text_text_color="#0A2E4A" text_font_size="16px" link_font="||||on||||" link_text_color="#FFFFFF" header_text_align="left" header_4_font="||||||||" header_4_text_align="left" header_4_text_color="#0A2E4A" header_4_font_size="19px" hover_enabled="0" global_colors_info="{}" theme_builder_area="post_content" sticky_enabled="0"]
VP & Global Head of Diagnostics
[/et_pb_text][et_pb_text _builder_version="4.24.0" _module_preset="default" text_font="||||||||" text_text_color="#0A2E4A" text_font_size="16px" link_font="||||on||||" link_text_color="#FFFFFF" header_text_align="left" header_4_font="||||||||" header_4_text_align="left" header_4_text_color="#0A2E4A" header_4_font_size="19px" global_colors_info="{}" theme_builder_area="post_content"]
SOPHiA GENETICS
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
